JSM Enzymology and Protein Science

The Functions of CHIP in Age Related Disease

Review Article | Open Access | Volume 2 | Issue 1

  • 1. Institute of Genetics and Molecular Medicine, University of Edinburgh, UK
+ Show More - Show Less
Corresponding Authors
Kathryn L Ball, The Institute of Genetics and Molecular Medicine, Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Crewe Road South, EH4 2XR, UK, Tel: +44 0-131-651-8500

CHIP is a key component of the protein homeostasis or ‘Proteostasis’ network that maintains protein structure and function as a way to ensure the integrity of the proteome in individual cells and the health of the whole organism. Proteostasis influences the biogenesis, folding, trafficking and degradation of proteins. Originally identified as a Hsc70 associated protein and a co-chaperone CHIP has E3-ubiquitin ligase activity and also displays an intrinsic chaperoning ability. It has become clear that CHIP is a multi-functional protein with roles in cellular processes that go beyond
its co-chaperone activity. Not surprisingly, by unravelling the functions of CHIP, we are beginning to appreciate that loss of CHIP’s integrity can lead to the development of several serious pathological conditions. Here we will describe the key features of CHIPs structure and functions with an emphasis on the non-canonical activities of CHIP before concentrating on the role it plays in protecting against the age associated pathologies of neurodegeneration and cancer.


Ball KL, Ning J, Nita E, Dias C (2016) The Functions of CHIP in Age Related Disease. JSM Enzymol Protein Sci 1(1): 1006


rRNA: Ribosome Ribonucleic Acid; RPM: Revolution Per Minute; p-NPP: Para - Nitrophenyl Palmitate; BSA, Bovine Serum Albumin; SDS - PAGE: Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis; (v/v): Volume/Volume; EDTA: Ethylene Diamine Tetra-acetic Acid; SDS: Sodium Dodecyl Sulfate


Pseudomonas genus, commonly present in soil and water [1] has considerable scientific and technological significance and consists of variety of organisms with ability to utilize wide range of simple and complex organic compounds [2]. Recently significant consideration has been given to explore Pseudomonas species because of their importance in the field of medicine, environmental microbiology, food technology, bio - energy and phytopathology [3]. They are known to bring about the biodegradation of natural and man - made toxic chemical compounds. Apart from that, the bacterial genus Pseudomonas is a remarkable producer of a number of extracellular enzymes, including lipase [1,4,5]. Lipases (E.C. are interfacial enzymes with tendency to catalyze the hydrolysis of ester bonds in long chain triacylglycerols to release free fatty acids [6]. Due to their unique biotechnological versatility and their capability to catalyze wide range of biochemical reactions, such as the synthesis of agrochemicals, pharmaceutical intermediates and flavor compounds, they are in focus recently [7,8]. Microbial lipases are more stable than the one attained from animals and plants, while those produced from Acinetobacter, Bacillus, Staphylococcus and Pseudomonas have revealed high stereo and region - selectivity, making them important enzymes in Biocatalysis [8,9]. The reactions being catalyzed by the lipases in the presence of organic solvents have many advantages. However lipases tends to deactivate in the presence of organic solvents, especially hydrophilic ones, due to the ability of the solvent to strip off water molecules from enzyme surface, thus leading to deactivation of the enzyme [10]. In order to reduce this problem certain strategies such as immobilization, chemical modification and protein engineering have been utilized for the stabilization of enzymes for use in such solvents [11]. It has been proposed to screen for naturally evolved solvent tolerant lipases instead of modified lipases.

The lipases obtained from microbial origin are utilized in variety of applications including food, dairy, detergents, pharmaceutical, cosmetics and biodiesel industries [12]. Each application requires particular properties of lipases with respect to temperature, pH and stability in organic solvents [13]. The lipase activity is highly dependent on pH and any change in the pH of the reaction mixture can affect the reaction kinetics. The enzymes stable at high temperatures are also very useful in industrial applications due to high reaction rates at elevated temperatures, while stability of enzymes in the presence of metal ions and organic solvents provides extra advantage in the overall outcome of the process [14]. In the present work, a novel solvent tolerant extracellular lipase from newly isolated Pseudomonas aeruginosa FW_SH-1 was purified by acetone precipitation and ion exchange chromatography. The purified lipase was characterized and compared with lipases obtained from other bacterial strains.


Microorganism and chemicals Pseudomonas aeruginosa FW_ SH-1, which produced the alkaline and organic solvent tolerant lipase, was used in the present study. The strain was isolated and identified in our laboratory; the partial 16S rRNA gene sequence from strain (FW_SH-1) was deposited in Gen Bank database under accession number KJ510652. The Phylogenetic tree was constructed by using molecular evolutionary genetics analysis (MEGA-6) software [15] which confirms that the isolated strain belongs to the genus Pseudomonas (Figure 1). P. aeruginosa strain was cultivated in a medium that was previously optimized nutritionally and physically for lipase production in our laboratory [16]. All of the media components were of analytic grade. Para- nitrophenyl palmitate (p - NPP) was obtained from sigma chemicals, USA; Q - Sepharose columns were purchased from GE healthcare bioscience, Sweden. Molecular weight markers were obtained from Ding Guo, Shanghai, China.

Inoculum preparation

P. aeruginosa was maintained on agar slant and kept at 4°C. A loopful of stock culture was transferred into a nutrient medium and utilized as inoculum. The inoculum culture was cultivated at 37°C and 150 rpm for overnight.

Lipase production

The lipase production medium contained peanut oil (15 mL/L), sucrose (3.5 g/L), tryptone (1 g/L), (NH4 )2 SO4 (2.8 g/L), MgSO4 (0.5 g/L), K2 HPO4 (2 g/L), KH2 PO4 (2 g/L) and NaCl (0.2 g/L) that were used to cultivate lipase from P. aeruginosa. The cultivation was carried out at 37°C and 150 rpm for 48 h using 3% (v/v) inoculum. Samples were collected at regular intervals and centrifuged at 12,000 × g at 4°C for 20 min. The cell free supernatant was used as a crude enzyme to determine the lipase activity from it by following standard lipase assay conditions.

Measurement of lipase activity

Extracellular lipase activity was measured spectrophotometrically by Winkler and Stuckman (1979) method with slight modifications. The substrate solution containing 10 mL of isopropanol with 30 mg of p-NPP was mixed with 90 mL of Tris-HCl buffer (0.05 M, pH 7.2), containing 0.4 % Triton-X-100 and 0.1% of gum Arabic [17]. Freshly prepared substrate solution (2.5 mL) was incubated at 37°C with 50 µL of lipase for 10 min. After incubation absorbance was measured at 410 nm by using a spectrophotometer against a control without enzyme. One unit of enzyme is defined as the amount of enzyme liberating 1 µmole of p-nitrophenol (p-NP) mL-1 min-1 under the assay conditions.

Purification of lipase

The cell free supernatant (crude lipase) was used for the purification of lipase. The crude lipase medium was first introduced to acetone precipitation. The ice cooled acetone was added to the tubes containing crude lipase mixture. The acetone added were four times the volume of supernatant. The mixture was than vortexed and incubated for 60 min at -20°C. The precipitated mixture was then centrifuged for 15 min at 12,000 × g at 4°C. The pellets obtained were dissolved in 0.5 M Tris-HCl (pH 8.0) buffer. The solution was analyzed for lipase activity and protein concentration.

The partially purified lipase in buffer solution was then treated with anion exchange chromatography. The column was packed with 5 ml of anion exchange Q - Sepharose sorbent slurry (size 3 × 1.5 cm) (GE Biosciences, Uppsala, Sweden). The column was first equilibrated with a three column volume of 50 mM TrisHCl buffer (pH 8.0) containing the enzyme. Then the column was washed with five column volume of the same buffer to eliminate the unbound lipase. The bounded lipase was eluted by the elution buffer with the step wise increment of NaCl from 50 mM to 150 mM. All of the eluted fractions were analyzed for lipase activity. The fractions with highest lipase activity were pooled and analyzed for protein content. Thus, the specific activity of the purified lipase was compared with that of the crude lipase and the purification fold was determined.

Protein estimation

The protein concentration was determined, according to the Bradford method [18], utilizing the Bradford reagent and bovine serum albumin (BSA) as the standard.

Determination of molecular weight: Sodium dodecyl sulfate - polyacrylamide gel electrophoresis (SDS-PAGE) was used to determine the molecular weight of the purified lipase as described by Laemmli [19]. The relative molecular mass was determined by comparing with molecular markers (20 - 97 kDa). Purified lipase was subjected to SDS - PAGE after boiling for 10 min. Then upon electrophoresis the gel was dyed for overnight. The protein bands were visualized by coomassie brilliant blue R-250. Then the gel was washed with decolorizing solution, followed by immersing the gel in water in order to swell the gel before being visualized for occurrence of protein bands.

Characterization of purified lipase

Effect of pH and temperature on lipase activity: The effect of pH on lipase activity was investigated by using different buffer systems in the pH range (4-9) at concentration of 50 mM: sodium acetate buffer (pH 4-5), sodium phosphate buffer (pH 6-7) and Tris-HCl buffer (pH 8-9). To conduct the lipase stability studies, 300 µL of the purified lipase solution was mixed with 700 µL of 50 mM buffer at specific pH value. The mixture was incubated at 37°C for 60 min and then the residual activity was determined. The effect of temperature on lipase activity was studied at different temperatures (25, 35, 45, 55 and 65°C) under optimized pH 8.0. The lipase thermal stability was analyzed by incubation of 100 µL of purified lipase solution at desired temperatures for 60 min. The remaining lipase activity was measured by using standard lipase assay conditions as described previously.

Effect of organic solvents on lipase activity: The effect of organic solvents on the lipase activity of the purified lipase was monitored. The organic solvents included methanol, ethanol, propanol, benzene, toluene, hexane, butanol, acetone, methyl acetate, heptane and octane that were used to analyze solvents effect on purified lipase. The concentrations of all the organic solvents were kept at 25% (v/v). 50 µL of organic solvents was added to 150 µL of the purified lipase solution. The mixture was incubated for 60 min at 45°C and 150 rpm. The remaining lipase activity was determined by following standard lipase assay conditions, while the residual activities were calculated by comparing the enzyme activities of purified lipase with and without solvent. The effect of propanol on purified lipase with different concentrations (50, 75, and 100 % v/v) by using the same method as described above was also studied.

Effect of metal ions and inhibitors on lipase activity: The effects of different metal ions such as Ca2+, Mg2+, Zn2+, Mn2+, Fe3+, Cu2+, Na+ , K+ and Al3+ ions (CaCl2 , MgCl2 , ZnSO4 , MnCl2 , FeCl3 , CuSO4 , NaCl, KCl and AlCl3 respectively) on lipase activity were analyzed. All the salt - ions solutions were prepared and maintained at the final concentration of 1 and 5 mM. The mixture containing 500 µL of lipase and 500 µL of salt - ions was incubated for 60 min at 45°C and 150 rpm. The effects of various inhibitors such as EDTA, SDS, Triton X-100 and Tween-80 on lipase activity were also studied. All of the inhibitors were separately maintained at concentration of 1 and 5 mM. The mixture containing 500 µL of lipase and 500 µL of inhibitors was incubated for 60 min at 45°C and 150 rpm. Then the lipase activity was assayed and the residual lipase activity was calculated by comparing the lipase activities in the presence and absence of the effectors. All of the experiments were performed in triplicates.


Purification of lipase

The lipase in the cell free supernatant (22.031 U/mg) was precipitated using acetone. The precipitated protein was dissolved in 50mM Tris-HCl (pH-8) buffer. The precipitated lipase showed the specific lipase activity of 105.75 U/mg with 4.77 fold purification. Lipase was further purified by the Q - sepharose anion exchange chromatography. The partially purified lipase was loaded into the ion exchange column and the binding enzyme was eluted out at 150 mM concentration of NaCl. The enzyme was purified to approximately 26 fold with a specific activity of 572.02 U/mL and an overall yield of 10.21 %. The purification results are summarized in Table (1). According to the previous reports, Aneurinibacillus thermoaerophilus strain HZ producing organic solvent tolerant lipase was purified to 15.62 fold with an overall yield of 19.69 % [20]. Lipase from Pseudomonas aeruginosa LX1 has been purified by using ammonium sulphate precipitation and DEAE - sepharose ion exchange chromatography with purification fold of 4.3 and an overall yield of 41.1% [21]. In the present work we have used two purification steps to purify the enzyme, thus obtaining purification of 26 - fold and specific activity of 572 U/mg.

Determination of Molecular weight

SDS - PAGE was used to confirm the homogeneity of the eluted protein. The purified lipase showed the single band on 10% polyacrylamide gel in the presence of SDS (Figure 2). The single protein band with a molecular weight of approximately 66 kDa indicated that the lipase was novel enzyme from P. aeruginosa strain. The molecular weight of 66 kDa of lipase from Pseudomonas sp. has not been determined before. Hence it suggests that this lipase has novel characteristics. On the other hand lower molecular weight of lipase from Pseudomonas aeruginosa LST-03 of around 27.1 kDa has been reported [22]. Whereas higher molecular weight of around 54 kDa has been reported from a thermo stable lipase from Pseudomonas aeruginosa San-ai [23]. The highest molecular weight of lipase from P. aeruginosa strain has been reported to be 60 kDa [24]. Mesophilic lipases from many Pseudomonas sp. have been found to possess a molecular weight of 44-60 kDa [21].

Characterization of lipase

Effect of pH on lipase activity: The purified lipase from P. aeruginosa was able to tolerate wide range of pH from 6.0 to 9.0. The maximum relative activity was recorded at pH 8.0 as shown in Figure (3). The lipase activity significantly dropped when the pH was increased up to 9.0 where relative activity approaches 74%. Also the activity was reduced considerably at pH value below 6.0 and a loss of 60% of the maximal activity occurred. The good stability of enzyme in broad pH range was due to firmness of the secondary structure of lipase in the present work and the similar sort of pH activity and stability trends were also reported previously [25,26]. Singh et al., (2007) has also found stable alkaline lipase from P. aeruginosa strain with excellent stability in pH range of 7-9 [27]. Whereas Ji et al., (2010) has reported a lipase which retains its maximum activity at pH 7.0 while its activity decreased sharply with increasing or decreasing the pH value even for single unit [21].

Effect of temperature on lipase activity: The purified enzyme was active in the range of temperature from 25 to 55°C with higher activity recorded at 45°C as shown in Figure (4). The maximum relative activity was observed to be 110 ± 2.42% at 45°C as compared to control. The relative activity of lipase decreased sharply from 85% to 45% in the temperature range of 55-65°C respectively. Similar trends of temperature stability of purified lipase from mesophilic strains have also been noticed previously [28,29].

Effect of organic solvents on lipase activity: The lipase has a good stability in hydrophilic solvents such as methanol, ethanol and propanol as shown in Table (2). The highest effect was observed with 25% (v/v) of propanol and ethanol showing 103.3% ± 1.86 and 97.21% ± 2.26 respectively. Closed chain organic solvents such as benzene and toluene had affected the activity of lipase in adverse way with 77.05% ± 2.63 and 79.66% ± 1.76 of relative activity recorded. Whereas hydrophobic long chain alkanes heptanes and octane negatively affected the activity and around 46% and 50% loss of activity occurred. Generally hydrophilic solvents cause more adverse enzyme denaturation as compared to hydrophobic ones [26] but in the present work the trend is different. The good stability in the polar solvents makes the lipase very useful to catalyze transesterification reaction to produce biodiesel. Yoo et al., (2011) has also found hydrophilic solvent ethanol as the most stabilizing solvent for its lipase with residual activity of 108.44% ± 5.2 recorded at 25% (v/v) of ethanol in lipase [30]. As the concentration of propanol increased the relative activity further decreased as shown in Table (2).

Effect of metal ions on lipase activity: The presence of metal ions such as Ca2+ and Mg2+ at concentration of 1mM and 5 mM have increased lipase activity up to 5-15% more than the control, while 5mM of Na+ and K+ ions have promoted the activity up to 12-14%. (Table 3) indicates that the purified lipase in the present work has been stable in variety of metal ions. On the other hand metal ions such as Zn2+, Mn2+, Cu2+ and Al3+ has adversely affected the lipase activity with zinc affecting the most with 28% loss in activity at concentration of 1mM, while aluminum affected the most with 35% loss in activity at concentration of 5mM. Jiewie et al., (2014) has also found the presence of K+ and Na+ ions to increase the relative activity [31]. Sivaramakrishnan et al., (2012) also has found Ca2+, Mg2+ and K+ ions to be positively affecting the relative activity of its purified lipase obtained from bacterial strain [32]. Whereas Mander et al., (2012) has discovered that the presence of Ca2+ ions significantly deteriorates the relative activity up to 40% while Mg2+ and Na+ ions elevates the relative activity [33].

Effect of inhibitors on lipase activity: The lipase was sensitive to the presence of EDTA and SDS at the concentration of 1-5 mM. EDTA with a concentration of 5mM significantly reduced the lipase activity around 46% as shown in Table (4). The surfactant SDS reduced the lipase activity up to 42%. The lipase activity was more affected with higher concentration of Triton X-100; with 1mM concentration, 12% loss in activity took place, while at 5mM concentration 22% loss in activity occurred. Both Tween-20 and Tween-80 have positively affected the lipase with increase in relative activity up to 2-6% as compared to the control. Dharmsthiti et al., (1998) also has found its lipase to be inactivated by EDTA, while the enzymes activity enhanced with Tween-20 and Tween-80 [34].


Pseudomonas aeruginosa FW_SH-1 is a source of novel lipase and with high specific activity and good stability in organic solvents makes the enzyme very useful for biotechnological applications. An effective approach of purifying the enzyme using acetone precipitation and Q - sepharose anion exchange chromatography with overall yield of 10.21% was carried out. The SDS - PAGE confirmed the presence of purified lipase, with a molecular weight of 66 kDa. The purified enzyme had optimum temperature and pH of 45°C and 8.0 respectively. The metal ions such as Ca2+, Mg2+, Na+ , K+ and Tween (20 and 80) as surfactants were found to enhance the relative activity. The organic solvents such as methanol, ethanol and propanol had a very little effect in deactivating the lipase. The properties of purified lipase make it a very favorable biocatalyst for catalyzing various reactions in presence of short chain polar organic solvents.


This first author cordially thanks Pakistan Govt. & Higher Education Commission (HEC) 294 for funding his PhD studies. This work was supported by the National Natural Science 295 Foundation of China (Grant No. 41273084) and the 863 Program (Grant 296 No.2013AA064403).


1. Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, Yin LY, et al. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol. 1999; 19: 4535-4545.

2. Aravind L, Koonin EV. The U box is a modified RING finger - a common domain in ubiquitination. Curr Biol. 2000; 10: 132-134.

3. Dou H, Buetow L, Sibbet GJ, Cameron K, Huang DT. BIRC7-E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer. Nat Struct Mol Biol. 2012; 19: 876-883.

4. Plechanovová A, Jaffray EG, Tatham MH, Naismith JH, Hay RT. Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis. Nature. 2012; 489: 115-120.

5. Cyr DM, Höhfeld J, Patterson C. Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. Trends Biochem Sci. 2002; 27: 368-375.

6. Alberti S, Demand J, Esser C, Emmerich N, Schild H, Hohfeld J. Ubiquitylation of BAG-1 suggests a novel regulatory mechanism during the sorting of chaperone substrates to the proteasome. J Biol Chem. 2002; 277: 45920-45927.

7. Pickart CM, Eddins MJ. Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta. 2004; 1695: 55-72.

8. Wu X, Karin M. Emerging roles of Lys63-linked polyubiquitylation in immune responses. Immunol Rev. 2015; 266: 161-174.

9. Wang G, Gao Y, Li L, Jin G, Cai Z, Chao JI, et al. K63-linked ubiquitination in kinase activation and cancer. Front Oncol. 2012; 2: 5.

10. Zhang M, Windheim M, Roe SM, Peggie M, Cohen P, Prodromou C, et al. Chaperoned ubiquitylation--crystal structures of the CHIP U box E3 ubiquitin ligase and a CHIP-Ubc13-Uev1a complex. Mol Cell. 2005; 20: 525-538.

11. Xu Z, Devlin KI, Ford MG, Nix JC, Qin J, Misra S. Structure and interactions of the helical and U-box domains of CHIP, the C terminus of HSP70 interacting protein. Biochemistry. 2006; 45: 4749-4759. 

12. Xu Z, Kohli E, Devlin KI, Bold M, Nix JC, Misra S. Interactions between the quality control ubiquitin ligase CHIP and ubiquitin conjugating enzymes. BMC Struct Biol. 2008; 8: 26.

13. Zeytuni N, Zarivach R. Structural and functional discussion of the tetra-trico-peptide repeat, a protein interaction module. Structure. 2012; 20: 397-405.

14. Blatch GL, Lässle M. The tetratricopeptide repeat: a structural motif mediating protein-protein interactions. Bioessays. 1999; 21: 932-939.

15. Andrade MA, Perez-Iratxeta C, Ponting CP. Protein repeats: structures, functions, and evolution. J Struct Biol. 2001; 134: 117-131.

16. Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Höhfeld J, et al. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol. 2001; 3: 93-96.

17. Zhang H, Amick J, Chakravarti R, Santarriaga S, Schlanger S, McGlone C, et al. A bipartite interaction between Hsp70 and CHIP regulates ubiquitination of chaperoned client proteins. Structure. 2015; 23: 472-482.

18. Nikolay R, Wiederkehr T, Rist W, Kramer G, Mayer MP, Bukau B. Dimerization of the human E3 ligase CHIP via a coiled-coil domain is essential for its activity. J Biol Chem. 2004; 279: 2673-2678.

19. Graf C, Stankiewicz M, Nikolay R, Mayer MP. Insights into the conformational dynamics of the E3 ubiquitin ligase CHIP in complex with chaperones and E2 enzymes. Biochemistry. 2010; 49: 2121- 2129.

20. Narayan V, Landre V, Ning J, Hernychova L, Muller P, Verma C, et al. Protein-Protein Interactions Modulate the Docking-Dependent E3- Ubiquitin Ligase Activity of Carboxy-Terminus of Hsc70-Interacting Protein (CHIP). Mol Cell Proteomics. 2015; 14: 2973-2987.

21. Blackburn EA, Wear MA, Landre V, Narayan V, Ning J, Erman B, et al. Cyclophilin40 isomerase activity is regulated by a temperaturedependent allosteric interaction with Hsp90. Biosci Rep. 2015; 35. 

22. Jiang J, Ballinger CA, Wu Y, Dai Q, Cyr DM, Höhfeld J, et al. CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation. J Biol Chem. 2001; 276: 42938-42944.

23. Demand J, Alberti S, Patterson C, Höhfeld J. Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/ proteasome coupling. Curr Biol. 2001; 11: 1569-1577.

24. Murata S, Minami Y, Minami M, Chiba T, Tanaka K. CHIP is a chaperonedependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep. 2001; 2: 1133-1138.

25. Esser C, Scheffner M, Höhfeld J. The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation. J Biol Chem. 2005; 280: 27443-27448. 

26. Edkins AL. CHIP: a co-chaperone for degradation by the proteasome. Subcell Biochem. 2015; 78: 219-242. 

27. McDonough H, Patterson C. CHIP: a link between the chaperone and proteasome systems. Cell Stress Chaperones. 2003; 8: 303-308.

28. Paul I, Ghosh MK. The E3 ligase CHIP: insights into its structure and regulation. Biomed Res Int. 2014; 2014: 918183. 

29. Meacham GC, Patterson C, Zhang W, Younger JM, Cyr DM. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat Cell Biol. 2001; 3: 100-105.

30. Kampinga HH1, Kanon B, Salomons FA, Kabakov AE, Patterson C. Over expression of the cochaperone CHIP enhances Hsp70-dependent folding activity in mammalian cells. Mol Cell Biol. 2003; 23: 4948- 4958.

31. Narayan V, Pion E, Landre V, Muller P, Ball KL. Docking-dependent ubiquitination of the interferon regulatory factor-1 tumor suppressor protein by the ubiquitin ligase CHIP. J Biol Chem. 2011; 286: 607-619.

32. Rosser MF, Washburn E, Muchowski PJ, Patterson C, Cyr DM. Chaperone functions of the E3 ubiquitin ligase CHIP. J Biol Chem. 2007; 282: 22267-22277.

33. Tripathi V, Ali A, Bhat R, Pati U. CHIP chaperones wild type p53 tumor suppressor protein. J Biol Chem. 2007; 282: 28441-28454.

34. Schisler JC, Rubel CE, Zhang C, Lockyer P, Cyr DM, Patterson C. CHIP protects against cardiac pressure overload through regulation of AMPK. J Clin Invest. 2013; 123: 3588-3599.

35. Gidalevitz T, Prahlad V, Morimoto RI. The stress of protein misfolding: from single cells to multicellular organisms. Cold Spring Harb Perspect Biol. 2011; 3: 009704.

36. Cotto JJ, Morimoto RI. Stress-induced activation of the heat-shock response: cell and molecular biology of heat-shock factors. Biochem Soc Symp. 1999; 64: 105-118.

37. Dai Q, Zhang C, Wu Y, McDonough H, Whaley RA, Godfrey V, et al. CHIP activates HSF1 and confers protection against apoptosis and cellular stress. EMBO J. 2003; 22: 5446-5458.

38. Qian SB, McDonough H, Boellmann F, Cyr DM, Patterson C. CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70. Nature. 2006; 440: 551-555.

39. Kim SA, Yoon JH, Kim DK, Kim SG, Ahn SG. CHIP interacts with heat shock factor 1 during heat stress. FEBS Lett. 2005; 579: 6559-6563.

40. Shi Y, Mosser DD, Morimoto RI. Molecular chaperones as HSF1-specific transcriptional repressors. Genes Dev. 1998; 12: 654-666.

41. Landré V, Pion E, Narayan V, Xirodimas DP, Ball KL. DNA-binding regulates site-specific ubiquitination of IRF-1. Biochem J. 2013; 449: 707-717.

42. Li RF, Shang Y, Liu D, Ren ZS, Chang Z, Sui SF. Differential ubiquitination of Smad1 mediated by CHIP: implications in the regulation of the bone morphogenetic protein signaling pathway. J Mol Biol. 2007; 374: 777- 790.

43. Kalia SK, Lee S, Smith PD, Liu L, Crocker SJ, Thorarinsdottir TE, et al. BAG5 inhibits parkin and enhances dopaminergic neuron degeneration. Neuron. 2004; 44: 931-945.

44. McDonough H, Charles PC, Hilliard EG, Qian SB, Min JN, Portbury A, et al. Stress-dependent Daxx-CHIP interaction suppresses the p53 apoptotic program. J Biol Chem. 2009; 284: 20649-20659.

45. Hwang JR, Zhang C, Patterson C. C-terminus of heat shock protein 70-interacting protein facilitates degradation of apoptosis signalregulating kinase 1 and inhibits apoptosis signal-regulating kinase 1-dependent apoptosis. Cell Stress Chaperones. 2005; 10: 147-156.

46. Jiang J, Cyr D, Babbitt RW, Sessa WC, Patterson C. Chaperone-dependent regulation of endothelial nitric-oxide synthase intracellular trafficking by the co-chaperone/ubiquitin ligase CHIP. J Biol Chem. 2003; 278: 49332-49341.

47. Kettern N, Rogon C, Limmer A, Schild H, Hohfeld J. The Hsc/Hsp70 co-chaperone network controls antigen aggregation and presentation during maturation of professional antigen presenting cells. PLoS One. 2011; 6: 16398.

48. Yang M, Wang C, Zhu X, Tang S, Shi L, Cao X, et al. E3 ubiquitin ligase CHIP facilitates Toll-like receptor signaling by recruiting and polyubiquitinating Src and atypical PKC{zeta}. J Exp Med. 2011; 208: 2099-2112.

49. Ronnebaum SM, Wu Y, McDonough H, Patterson C. The ubiquitin ligase CHIP prevents SirT6 degradation through noncanonical ubiquitination. Mol Cell Biol. 2013; 33: 4461-4472.

50. Liu X, Huang S, Wang X, Tang B, Li W, Mao Z. Chaperone-mediated autophagy and neurodegeneration: connections, mechanisms, and therapeutic implications. Neurosci Bull. 2015; 31: 407-415.

51. Guo D, Ying Z, Wang H, Chen D, Gao F, Ren H, et al. Regulation of autophagic flux by CHIP. Neurosci Bull. 2015; 31: 469-479.

52. Palubinsky AM, Stankowski JN, Kale AC, Codreanu SG, Singer RJ, Liebler DC, et al. CHIP Is an Essential Determinant of Neuronal Mitochondrial Stress Signaling. Antioxid Redox Signal. 2015; 23: 535-549.

53. Arndt V, Dick N, Tawo R, Dreiseidler M, Wenzel D, Hesse M, et al. Chaperone-assisted selective autophagy is essential for muscle maintenance. Curr Biol. 2010; 20: 143-148.

54. Orenstein SJ, Cuervo AM. Chaperone-mediated autophagy: molecular mechanisms and physiological relevance. Semin Cell Dev Biol. 2010; 21: 719-726.

55. Cuervo AM. Chaperone-mediated autophagy: selectivity pays off. Trends Endocrinol Metab. 2010; 21: 142-150. 56.Luo W, Zhong J, Chang R, Hu H, Pandey A, Semenza GL. Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha. J Biol Chem. 2010; 285: 3651-3663.

57. Ferreira JV, Fôfo H, Bejarano E, Bento CF, Ramalho JS, Girão H, et al. STUB1/CHIP is required for HIF1A degradation by chaperone-mediated autophagy. Autophagy. 2013; 9: 1349-1366.

58. Min JN, Whaley RA, Sharpless NE, Lockyer P, Portbury AL, Patterson C. CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control. Mol Cell Biol. 2008; 28: 4018-4025.

59. Chen JH, Hales CN, Ozanne SE. DNA damage, cellular senescence and organismal ageing: causal or correlative? Nucleic Acids Res. 2007; 35: 7417-7428.

60. Sisoula C, Gonos ES. CHIP E3 ligase regulates mammalian senescence by modulating the levels of oxidized proteins. Mech Ageing Dev. 2011; 132: 269-272.

61. Tsvetkov P, Adamovich Y, Elliott E, Shaul Y. E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients. J Biol Chem. 2011; 286: 8839-8845.

62. Asher G, Tsvetkov P, Kahana C, Shaul Y. A mechanism of ubiquitinindependent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev. 2005; 19: 316-321.

63. Lee JS, Seo TW, Yi JH, Shin KS, Yoo SJ. CHIP has a protective role against oxidative stress-induced cell death through specific regulation of endonuclease G. Cell Death Dis. 2013; 4: 666.

64. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature. 2001; 412: 95-99.

65. Nunan J, Shearman MS, Checler F, Cappai R, Evin G, Beyreuther K, et al. The C-terminal fragment of the Alzheimer’s disease amyloid protein precursor is degraded by a proteasome-dependent mechanism Central Bringing Excellence in Open Access -Ball et al. (2016) Email: JSM Enzymol Protein Sci 1(1): 1006 (2016) 10/10 distinct from gamma-secretase. Eur J Biochem. 2001; 268: 5329-5336.

66. Kumar P, Ambasta RK, Veereshwarayya V, Rosen KM, Kosik KS, Band H, et al. CHIP and HSPs interact with beta-APP in a proteasomedependent manner and influence Abeta metabolism. Hum Mol Genet. 2007; 16: 848-864.

67. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A. 1986; 83: 4913-4917.

68. Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, Grover A, et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet. 2004; 13: 703-714.

69. Saidi LJ, Polydoro M, Kay KR, Sanchez L, Mandelkow EM, Hyman BT, et al. Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes. J Alzheimers Dis. 2015; 44: 937-947.

70. Dickey CA, Yue M, Lin WL, Dickson DW, Dunmore JH, Lee WC, et al. Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3- cleaved tau species. J Neurosci. 2006; 26: 6985-6996.

71. Dickey CA, Patterson C, Dickson D, Petrucelli L. Brain CHIP: removing the culprits in neurodegenerative disease. Trends Mol Med. 2007; 13: 32-38.

72. Sahara N, Murayama M, Mizoroki T, Urushitani M, Imai Y, Takahashi R, et al. In vivo evidence of CHIP up-regulation attenuating tau aggregation. J Neurochem. 2005; 94: 1254-1263.

73. Stoothoff W, Jones PB, Spires-Jones TL, Joyner D, Chhabra E, Bercury K, et al. Differential effect of three-repeat and four-repeat tau on mitochondrial axonal transport. J Neurochem. 2009; 111: 417-427.

74. Sahay S, Ghosh D, Singh PK, Maji SK. Alteration of Structure and Aggregation of a-Synuclein by Familial Parkinson’s Disease Associated Mutations. Curr Protein Pept Sci. 2016.

75. Chu Y, Kordower JH. The prion hypothesis of Parkinson’s disease. Curr Neurol Neurosci Rep. 2015; 15: 28.

76. Roberts HL, Brown DR. Seeking a mechanism for the toxicity of oligomeric alpha-synuclein. Biomolecules. 2015; 5: 282-305.

77. Shin Y, Klucken J, Patterson C, Hyman BT, McLean PJ. The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways. J Biol Chem. 2005; 280: 23727-23734.

78. Tetzlaff JE, Putcha P, Outeiro TF, Ivanov A, Berezovska O, Hyman BT, et al. CHIP targets toxic alpha-Synuclein oligomers for degradation. J Biol Chem. 2008; 283: 17962-17968.

79. Kalia LV, Kalia SK, Chau H, Lozano AM, Hyman BT, McLean PJ. Ubiquitinylation of α-synuclein by carboxyl terminus Hsp70- interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5). PLoS One. 2011; 6: 14695.

80. Uryu K, Richter-Landsberg C, Welch W, Sun E, Goldbaum O, Norris EH, et al. Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies. Am J Pathol. 2006; 168: 947-961.

81. Auluck PK, Bonini NM. Pharmacological prevention of Parkinson disease in Drosophila. Nat Med. 2002; 8: 1185-1186.

82. McLean PJ, Klucken J, Shin Y, Hyman BT. Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro. Biochem Biophys Res Commun. 2004; 321: 665-669.

83. Flower TR, Chesnokova LS, Froelich CA, Dixon C, Witt SN. Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson’s disease. J Mol Biol. 2005; 351: 1081-1100.

84. Min B, Park H, Lee S, Li Y, Choi JM, Lee JY, et al. CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer. Oncogene. 2016; 35: 3718-3728.

85. Zhang HT, Zeng LF, He QY, Tao WA, Zha ZG, Hu CD. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5. Biochim Biophys Acta. 2016; 1863: 335-346.

86. Paul I, Ghosh MK. A CHIPotle in physiology and disease. Int J Biochem Cell Biol. 2015; 58: 37-52.

87. Kajiro M, Hirota R, Nakajima Y, Kawanowa K, So-ma K, Ito I, et al. The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. Nat Cell Biol. 2009; 11: 312-319.

88. Wang Y1, Ren F, Wang Y, Feng Y, Wang D, Jia B , et al. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer. Carcinogenesis. 2014; 35: 983-91.

89. Kurozumi S, Yamaguchi Y, Hayashi SI, Hiyoshi H, Suda T, Gohno T, et al. Prognostic value of the ubiquitin ligase carboxyl terminus of the Hsc70-interacting protein in postmenopausal breast cancer. Cancer Med. 2016; 5: 1873-1882.

90. Abduljabbar R, Negm OH, Lai CF, Jerjees DA, Al-Kaabi M, Hamed MR, et al. Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer. Breast Cancer Res Treat. 2015; 150: 335- 346.

91. Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol. 2013; 75: 685-705.

92. Gu Z, Gao S, Zhang F, Wang Z, Ma W, Davis RE, et al. Protein arginine methyltransferase 5 is essential for growth of lung cancer cells. Biochem J. 2012; 446: 235-241.

93. Stopa N, Krebs JE, Shechter D. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond. Cell Mol Life Sci. 2015; 72: 2041-2059.

94. Wang L, Pal S, Sif S. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells. Mol Cell Biol. 2008; 28: 6262-6277.

95. Liu F, Zhou J, Zhou P, Chen W, Guo F. The ubiquitin ligase CHIP inactivates NF-κB signaling and impairs the ability of migration and invasion in gastric cancer cells. Int J Oncol. 2015; 46: 2096-2106.

96. Ru Y, Wang Q, Liu X, Zhang M, Zhong D, et al. The chimeric ubiquitin ligase SH2-U-box inhibits the growth of imatinib-sensitive and resistant CML by targeting the native and T315I-mutant BCR-ABL. Sci Rep. 2016; 6: 28352.

97. Kalia SK, Kalia LV, McLean PJ. Molecular chaperones as rational drug targets for Parkinson’s disease therapeutics. CNS Neurol Disord Drug Targets. 2010; 9: 741-753.

Received : 03 Aug 2016
Accepted : 29 Sep 2016
Published : 01 Oct 2016
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X